LATANOPROST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Latanoprost, and what generic alternatives are available?
Latanoprost is a drug marketed by Amring Pharms, Apotex Inc, Bausch And Lomb, Carnegie, Epic Pharma Llc, Eugia Pharma, Fdc Ltd, Sandoz, and Somerset. and is included in nine NDAs.
The generic ingredient in LATANOPROST is latanoprost. There are twenty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the latanoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Latanoprost
A generic version of LATANOPROST was approved as latanoprost by AMRING PHARMS on March 22nd, 2011.
Summary for LATANOPROST
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 190 |
Patent Applications: | 5,769 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LATANOPROST |
Drug Sales Revenues: | Drug sales revenues for LATANOPROST |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for LATANOPROST |
What excipients (inactive ingredients) are in LATANOPROST? | LATANOPROST excipients list |
DailyMed Link: | LATANOPROST at DailyMed |
Recent Clinical Trials for LATANOPROST
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Aneira Pharma, Inc. | Phase 1 |
DataPharm Australia, CMAX Clinical Research, Agilex Australia | Phase 1 |
Uzoma Chinyei Joan | Phase 4 |
Pharmacology for LATANOPROST
Drug Class | Prostaglandin Analog |
Anatomical Therapeutic Chemical (ATC) Classes for LATANOPROST
US Patents and Regulatory Information for LATANOPROST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amring Pharms | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 200925-001 | Mar 22, 2011 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fdc Ltd | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 202442-001 | Apr 22, 2016 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Carnegie | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 202077-001 | Feb 11, 2013 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 091449-001 | Mar 22, 2011 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Apotex Inc | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 077697-001 | Mar 22, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |